GoodRx Holdings (GoodRx Holdings) Risk Assessment

View and export this data going back to 2020. Start your Free Trial

What is GoodRx Holdings Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of GoodRx Holdings is: High Risk: High uncertainty with risk-return tradeoff.

Competitive Comparison of GoodRx Holdings's Risk Assessment

For the Health Information Services subindustry, GoodRx Holdings's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GoodRx Holdings's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's Risk Assessment distribution charts can be found below:

* The bar in red indicates where GoodRx Holdings's Risk Assessment falls into.

GoodRx Holdings (NAS:GDRX) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

GoodRx Holdings Risk Assessment Related Terms

Thank you for viewing the detailed overview of GoodRx Holdings's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

GoodRx Holdings (GoodRx Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GoodRx Holdings Inc (NAS:GDRX) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

2701 Olympic Boulevard, Santa Monica, CA, USA, 90404

Website

https://www.goodrx.com

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers other healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Executives

Scott Wagner	officer: Interim Chief Executive Office	C/O WILSON SONSINI GOODRICH AND ROSATI, 650 PAGE MILL ROAD, PALO ALTO CA 94304
Raj Beri	officer: Chief Operating Officer	C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Romin Nabiey	officer: Chief Accounting Officer	C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Andrew Slutsky	officer: President & Consumer	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Idea Men, Llc	10 percent owner	2701 OLYMPIC BOULEVARD, WEST BUILDING - SUITE 200, SANTA MONICA CA 90404
Karsten Voermann	officer: Chief Financial Officer	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Trevor Bezdek	director, officer: Co-CEO	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Abdiel Qualified Master Fund Lp	10 percent owner	90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Douglas Joseph Hirsch	director, officer: Co-CEO	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Babak Azad	officer: See Remarks	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Bansi Nagji	officer: President, Healthcare	MCKESSON CORPORATION, 6555 STATE HIGHWAY 161, IRVING TX 75039
Agnes Rey-giraud	director
Abdiel Capital Lp	10 percent owner	C/O ABDIEL CAPITAL ADVISORS, LP, 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Advisors, Lp	10 percent owner	90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Management, Llc	10 percent owner	90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016